News
BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive ...
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
23h
TipRanks on MSNBioNTech’s New PDAC Study: A Potential Game-Changer in Cancer Treatment?
The outcome of this study could significantly influence BioNTech’s stock performance and investor sentiment, especially if the combination therapy proves more effective than the standard treatment.
2d
Investor's Business Daily on MSNBioNTech ADR Meets 80-Plus Relative Strength Rating Benchmark
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
A large retrospective study found that nearly a quarter of high-grade serous cancers occurred after missed chances to perform ...
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
"This isn't a political statement," Dr. Lee Vogel said about vaccine safety. "This is just trying to provide some factual information for people." ...
The American Academy of Pediatrics says children 6 months to 2 years old really need a COVID vaccine, while the CDC says they ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results